580 related articles for article (PubMed ID: 20090319)
21. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
Yong M; Diener HC; Kaste M; Mau J
Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
[TBL] [Abstract][Full Text] [Related]
22. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
Okmen E; Cakmak M; Tartan Z; Cam N
Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
[TBL] [Abstract][Full Text] [Related]
23. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
24. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
[TBL] [Abstract][Full Text] [Related]
26. Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
Kim JW; Jeon P; Kim GM; Bang OY; Byun HS; Kim KH
Clin Neurol Neurosurg; 2012 Dec; 114(10):1316-9. PubMed ID: 22633401
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
[TBL] [Abstract][Full Text] [Related]
28. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
Shobha N; Buchan AM; Hill MD;
Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
[TBL] [Abstract][Full Text] [Related]
29. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
[TBL] [Abstract][Full Text] [Related]
30. Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
Lin L; Li W; Liu CC; Wu Y; Huang SH; Li XS; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Feng W; Zhang M
J Neurol Sci; 2017 Dec; 383():175-179. PubMed ID: 29246609
[TBL] [Abstract][Full Text] [Related]
31. NXY-059 for the treatment of acute ischemic stroke.
Shuaib A; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Diener HC; Ashwood T; Wasiewski WW; Emeribe U;
N Engl J Med; 2007 Aug; 357(6):562-71. PubMed ID: 17687131
[TBL] [Abstract][Full Text] [Related]
32. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
[TBL] [Abstract][Full Text] [Related]
33. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke.
Mangiafico S; Cellerini M; Nencini P; Gensini G; Inzitari D
AJNR Am J Neuroradiol; 2005; 26(10):2595-601. PubMed ID: 16286408
[TBL] [Abstract][Full Text] [Related]
34. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
Cohen M; Théroux P; Borzak S; Frey MJ; White HD; Van Mieghem W; Senatore F; Lis J; Mukherjee R; Harris K; Bigonzi F;
Am Heart J; 2002 Sep; 144(3):470-7. PubMed ID: 12228784
[TBL] [Abstract][Full Text] [Related]
35. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians.
Mono ML; Romagna L; Jung S; Arnold M; Galimanis A; Fischer U; Kohler A; Ballinari P; Brekenfeld C; Gralla J; Schroth G; Mattle HP; Nedeltchev K
Cerebrovasc Dis; 2012; 33(2):116-22. PubMed ID: 22179504
[TBL] [Abstract][Full Text] [Related]
36. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
37. Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
Zi W; Song J; Kong W; Huang J; Guo C; He W; Yu Y; Zhang B; Geng W; Tan X; Tian Y; Liu Z; Cao M; Cheng D; Li B; Huang W; Liu J; Wang P; Yu Z; Liang H; Yang S; Tang M; Liu W; Huang X; Liu S; Tang Y; Wu Y; Yao L; Shi Z; He P; Zhao H; Chen Z; Luo J; Wan Y; Shi Q; Wang M; Yang D; Chen X; Huang F; Mu J; Li H; Li Z; Zheng J; Xie S; Cai T; Peng Y; Xie W; Qiu Z; Liu C; Yue C; Li L; Tian Y; Yang D; Miao J; Yang J; Hu J; Nogueira RG; Wang D; Saver JL; Li F; Yang Q;
N Engl J Med; 2023 Jun; 388(22):2025-2036. PubMed ID: 37256974
[TBL] [Abstract][Full Text] [Related]
38. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
[TBL] [Abstract][Full Text] [Related]
39. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
[TBL] [Abstract][Full Text] [Related]
40. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
Machumpurath B; Davis SM; Yan B
Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
